Medicilon was awarded the "Industry Outstanding Member Unit Management Award" by the China Laborator

Medicilon was awarded the "Industry Outstanding Member Unit Management Award" by the China Laboratory Primate Breeding and Development Association

Recently, the China Laboratory Primate Breeding and Development Association Industry Academic Exchange Conference and 30th Anniversary Celebration were held as scheduled at the Dragon Lake Princess Hotel in Huadu, Guangzhou.  As a member, Shanghai Medicilon Inc. was invited to attend the conference and was awarded the "Industry Outstanding Member Unit Management Award".

Nonhuman primate research is an indispensable part of preclinical research and plays a link between basic research and clinical trial.  As a one-stop biopharmaceutical preclinical R&D service platform in China, Medicilon established a "non-human primate professional technical service platform" as early as 2008.  After nearly 16 years of experience and technology accumulation, the non-human primate professional technical service platform has established mature models in the fields of ophthalmic diseases, inflammatory and autoimmune diseases, endocrine, metabolic diseases and more.  Medicilon can provide pharmacodynamics, pharmacokinetics and safety evaluation tests in compliance with international and China GLP specifications, international AAALAC requirements, FDA standards and ICH requirements, providing strong support for promoting clinical development.

It is worth mentioning that Medicilon's "Professional Technical Service Platform for Non-Human Primates" has been selected into the Shanghai International Services Trade Demonstration Project.  At present, Medicilon has complete animal models such as mice, rats, rabbits, pigs, dogs, and monkeys, which can meet clients' different types of new drug research and development needs.  Among them, the non-human primate experimental facility is the largest laboratory in Shanghai with the largest number of monkeys.

Medicilon respects the life of experimental animals, pays attention to the welfare ethics of experimental animals, and actively implements the "3Rs" principles of use of experimental animals and the "Five Basic Welfare", providing different toys, sports facilities, nutritious fruits, play light music and cartoons for different species of experimental animals to ensure that the animals are in a comfortable, healthy, happy and natural living state.

In the future, Medicilon will maintain and protect the welfare of experimental animals, cherish every experimental opportunity, provide high-quality and efficient scientific research services for global new drug research and development, and empower the innovative development of life sciences.

PS: We would like to express our highest respect to all experimental animals that devote themselves to life sciences!